The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transcriptomics Market Research Report 2025
Synopsis
The global market for Transcriptomics was valued at US$ 4561 million in the year 2024 and is projected to reach a revised size of US$ 8808 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
The Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Transcriptomics was valued at US$ 4561 million in the year 2024 and is projected to reach a revised size of US$ 8808 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
The Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptomics Market Perspective (2020-2031)
2.2 Global Transcriptomics Growth Trends by Region
2.2.1 Global Transcriptomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transcriptomics Historic Market Size by Region (2020-2025)
2.2.3 Transcriptomics Forecasted Market Size by Region (2026-2031)
2.3 Transcriptomics Market Dynamics
2.3.1 Transcriptomics Industry Trends
2.3.2 Transcriptomics Market Drivers
2.3.3 Transcriptomics Market Challenges
2.3.4 Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptomics Players by Revenue
3.1.1 Global Top Transcriptomics Players by Revenue (2020-2025)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2020-2025)
3.2 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transcriptomics Revenue
3.4 Global Transcriptomics Market Concentration Ratio
3.4.1 Global Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptomics Revenue in 2024
3.5 Global Key Players of Transcriptomics Head office and Area Served
3.6 Global Key Players of Transcriptomics, Product and Application
3.7 Global Key Players of Transcriptomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptomics Breakdown Data by Type
4.1 Global Transcriptomics Historic Market Size by Type (2020-2025)
4.2 Global Transcriptomics Forecasted Market Size by Type (2026-2031)
5 Transcriptomics Breakdown Data by Application
5.1 Global Transcriptomics Historic Market Size by Application (2020-2025)
5.2 Global Transcriptomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transcriptomics Market Size (2020-2031)
6.2 North America Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transcriptomics Market Size by Country (2020-2025)
6.4 North America Transcriptomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptomics Market Size (2020-2031)
7.2 Europe Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transcriptomics Market Size by Country (2020-2025)
7.4 Europe Transcriptomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Market Size (2020-2031)
8.2 Asia-Pacific Transcriptomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transcriptomics Market Size by Region (2020-2025)
8.4 Asia-Pacific Transcriptomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptomics Market Size (2020-2031)
9.2 Latin America Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transcriptomics Market Size by Country (2020-2025)
9.4 Latin America Transcriptomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Market Size (2020-2031)
10.2 Middle East & Africa Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transcriptomics Market Size by Country (2020-2025)
10.4 Middle East & Africa Transcriptomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptomics Introduction
11.2.4 Illumina Revenue in Transcriptomics Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in Transcriptomics Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptomics Introduction
11.5.4 Roche Revenue in Transcriptomics Business (2020-2025)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptomics Introduction
11.6.4 GE Healthcare Revenue in Transcriptomics Business (2020-2025)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptomics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptomics Introduction
11.8.4 Fluidigm Revenue in Transcriptomics Business (2020-2025)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Transcriptomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of Microarray
Table 4. Key Players of Sequencing
Table 5. Global Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transcriptomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Transcriptomics Market Share by Region (2020-2025)
Table 9. Global Transcriptomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Transcriptomics Market Share by Region (2026-2031)
Table 11. Transcriptomics Market Trends
Table 12. Transcriptomics Market Drivers
Table 13. Transcriptomics Market Challenges
Table 14. Transcriptomics Market Restraints
Table 15. Global Transcriptomics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Transcriptomics Market Share by Players (2020-2025)
Table 17. Global Top Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptomics as of 2024)
Table 18. Ranking of Global Top Transcriptomics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Transcriptomics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Transcriptomics, Headquarters and Area Served
Table 21. Global Key Players of Transcriptomics, Product and Application
Table 22. Global Key Players of Transcriptomics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transcriptomics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Transcriptomics Revenue Market Share by Type (2020-2025)
Table 26. Global Transcriptomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Transcriptomics Revenue Market Share by Type (2026-2031)
Table 28. Global Transcriptomics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Transcriptomics Revenue Market Share by Application (2020-2025)
Table 30. Global Transcriptomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Transcriptomics Revenue Market Share by Application (2026-2031)
Table 32. North America Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Transcriptomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Transcriptomics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Transcriptomics Product
Table 50. Thermo Fisher Scientific Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Illumina Company Details
Table 53. Illumina Business Overview
Table 54. Illumina Transcriptomics Product
Table 55. Illumina Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 56. Illumina Recent Development
Table 57. QIAGEN (Exiqon) Company Details
Table 58. QIAGEN (Exiqon) Business Overview
Table 59. QIAGEN (Exiqon) Transcriptomics Product
Table 60. QIAGEN (Exiqon) Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 61. QIAGEN (Exiqon) Recent Development
Table 62. Agilent Technologies Company Details
Table 63. Agilent Technologies Business Overview
Table 64. Agilent Technologies Transcriptomics Product
Table 65. Agilent Technologies Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 66. Agilent Technologies Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Transcriptomics Product
Table 70. Roche Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 71. Roche Recent Development
Table 72. GE Healthcare Company Details
Table 73. GE Healthcare Business Overview
Table 74. GE Healthcare Transcriptomics Product
Table 75. GE Healthcare Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 76. GE Healthcare Recent Development
Table 77. Bio-Rad Laboratories Company Details
Table 78. Bio-Rad Laboratories Business Overview
Table 79. Bio-Rad Laboratories Transcriptomics Product
Table 80. Bio-Rad Laboratories Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 81. Bio-Rad Laboratories Recent Development
Table 82. Fluidigm Company Details
Table 83. Fluidigm Business Overview
Table 84. Fluidigm Transcriptomics Product
Table 85. Fluidigm Revenue in Transcriptomics Business (2020-2025) & (US$ Million)
Table 86. Fluidigm Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Transcriptomics Picture
Figure 2. Global Transcriptomics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transcriptomics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. Microarray Features
Figure 6. Sequencing Features
Figure 7. Global Transcriptomics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Transcriptomics Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical and Biotechnology Case Studies
Figure 10. Academic Research and Government Institutes Case Studies
Figure 11. Hospitals and Diagnostic Centers Case Studies
Figure 12. Transcriptomics Report Years Considered
Figure 13. Global Transcriptomics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Transcriptomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transcriptomics Market Share by Region: 2024 VS 2031
Figure 16. Global Transcriptomics Market Share by Players in 2024
Figure 17. Global Top Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptomics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Transcriptomics Revenue in 2024
Figure 19. North America Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Transcriptomics Market Share by Country (2020-2031)
Figure 21. United States Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transcriptomics Market Share by Country (2020-2031)
Figure 25. Germany Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transcriptomics Market Share by Region (2020-2031)
Figure 33. China Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transcriptomics Market Share by Country (2020-2031)
Figure 41. Mexico Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transcriptomics Market Share by Country (2020-2031)
Figure 45. Turkey Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 49. Illumina Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 50. QIAGEN (Exiqon) Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 51. Agilent Technologies Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 53. GE Healthcare Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 55. Fluidigm Revenue Growth Rate in Transcriptomics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
